SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-033059
Filing Date
2023-09-19
Accepted
2023-09-19 15:56:11
Documents
13
Period of Report
2023-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47617
2 ex10-1.htm EX-10.1 25048
  Complete submission text file 0001493152-23-033059.txt   248291

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sigy-20230914.xsd EX-101.SCH 3042
4 XBRL LABEL FILE sigy-20230914_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE sigy-20230914_pre.xml EX-101.PRE 22377
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3149
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 231263631
SIC: 3841 Surgical & Medical Instruments & Apparatus